New Gene Therapy for Sickle Cell Disease at Nemours
Dover News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Nemours Childrens Hospital in Delaware introduces Lyfgenia, a groundbreaking one-time gene therapy for sickle cell disease and beta thalassemia. This therapy, which involves modifying a patients own stem cells to produce healthy hemoglobin, has shown promising results in reducing pain episodes, emergency visits, and blood transfusions. With this new treatment, more children can look forward to fewer crises and improved quality of life.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/e8d25aaee017e0bb